Gut microbiota imbalance linked to higher UTI risks in women

FHS
June 7, 2024
2:14 am

Study reveals that gut microbial dysbiosis and frequent antibiotic use are key risk factors for recurrent urinary tract infections (UTIs) in women, emphasizing the importance of a healthy lifestyle and dietary supplements to prevent UTIs.

Jazz’s KRAS deal with Redx; Alto Neuroscience upsizes IPO

Plus, news about PepGen and Jasper Therapeutics: Jazz Pharmaceuticals buys Redx Pharma’s KRAS inhibitors: The company is paying Redx $10 million upfront, with milestones up

February 8, 2024

Study evaluating intranasal anti-CD3 for treatment of Alzheimer’s disease published in the PNAS journal

Tiziana Life Sciences Ltd. (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies via novel routes of drug delivery, today announced acceptance of

September 9, 2023

Aortic Stenosis Outcomes Worsen With Cardiac Amyloidosis Also in the Picture

AS plus ATTR-CA was associated with worse clinical outcomes than AS alone. Challenges of diagnosis stand in the way of timely treatment of ATTR-CA. Certain

January 17, 2025

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.